[Study of the expression and function of Syk and VEGF-C in the development of non-small cell lung cancer]

Jia-zhong Guo1, Qi-feng Sun1, Bo Cong1

  • 1Department of Surgery, the Second Hospital of Shandong University,Jinan 250033, China.

Zhonghua Yi Xue Za Zhi
|February 20, 2014
PubMed
Abstract

Insights

Spleen tyrosine kinase (Syk) and vascular endothelial growth factor C (VEGF-C) show a negative correlation in non-small cell lung cancer (NSCLC) tissues. VEGF-C promotes NSCLC cell invasion, suggesting a role in tumor development.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality.
  • Understanding the molecular mechanisms driving NSCLC progression is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the roles of Spleen tyrosine kinase (Syk) and Vascular Endothelial Growth Factor C (VEGF-C) in NSCLC development.
  • To explore the relationship between Syk and VEGF-C expression in NSCLC.

Main Methods:

  • Gene transfection of A549 cells with VEGF-C and Syk constructs.
  • Quantitative analysis of gene and protein expression using RT-PCR and immunohistochemistry.
  • In vitro cell invasion assays.
  • Correlation analysis of Syk and VEGF-C expression in NSCLC tissues.

Main Results:

  • VEGF-C and Syk expression were significantly upregulated in transfected A549 cells compared to controls.
  • Both VEGF-C and Syk overexpression increased NSCLC cell invasion.
  • Syk protein expression was lower in NSCLC tissues than in normal lung tissues, while VEGF-C expression was higher.
  • A significant negative correlation was observed between Syk and VEGF-C expression in NSCLC tissues.

Conclusions:

  • Syk and VEGF-C exhibit a negative correlation in NSCLC.
  • VEGF-C appears to enhance the aggressiveness of NSCLC cells.
  • These findings suggest a potential cooperative role for Syk and VEGF-C in NSCLC pathogenesis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Tumor Progression02:07

Tumor Progression

3.1K